P/B
8
Cibus
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
$118.5M
Market Cap • 10/9/2026
2010
(16 years)
Founded
2017
(9 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
27,3
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,2
EPS
—
Market Cap
Market Cap
118,5M
EV
130,8M
EV/Revenue
30,1
EV/EBITDA
-2,3
EV/EBIT
-2,1
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-31,3%
Total Yield
-31,3%
Payout
0%
Retained Earnings
-901,6M
Profitability
Gross Margin
100%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
860,2%
Capex/Revenue
6,1%
Capex/D&A
5,3%
Capex/OCF
-0,6%
SBC/OCF
—
% PPE
8,3%
% Goodwill
74,2%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-34,3%
CAGR Op. Income 5Y
10,8%
CAGR Net Income 5Y
21,4%
CAGR EPS 5Y
-50%
CAGR OCF 5Y
9,5%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
1,6
Quick Ratio
1,5
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!